Your browser doesn't support javascript.
loading
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh®TM) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
Dorman, Klara; Boeck, Stefan; Snijder, Robert J; Siveke, Jens T; Schenk, Michael; Mayerle, Julia; Caca, Karel; Freiberg-Richter, Jens; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Reinacher-Schick, Anke; Fuchs, Martin; Kanzler, Stephan; Kunzmann, Volker; Ettrich, Thomas J; Zhang, Danmei; Held, Swantje; Abdul-Ahad, Ayad; von Bergwelt-Baildon, Michael; Heinemann, Volker; Haas, Michael.
Afiliación
  • Dorman K; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig Maximilian University of Munich, Marchioninistr. 15, 81377 Munich, Germany.
  • Boeck S; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
  • Snijder RJ; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig Maximilian University of Munich, Marchioninistr. 15, 81377 Munich, Germany.
  • Siveke JT; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
  • Schenk M; BOTh Analytics GmbH, 80687 Munich, Germany.
  • Mayerle J; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, 45147 Essen, Germany.
  • Caca K; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, Partner site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.
  • Freiberg-Richter J; Department of Haematology and Oncology, Hospital Barmherzige Brüder, 93049 Regensburg, Germany.
  • Fischer von Weikersthal L; Department of Internal Medicine II, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Kullmann F; Department of Internal Medicine I, Klinikum Ludwigsburg, 71640 Ludwigsburg, Germany.
  • Reinacher-Schick A; Practice for Haematology and Oncology, 01307 Dresden, Germany.
  • Fuchs M; Department of Oncology, Gesundheitszentrum St. Marien, 92224 Amberg, Germany.
  • Kanzler S; Department of Medicine I, Klinikum Weiden, 92637 Weiden, Germany.
  • Kunzmann V; Department of Haematology and Oncology, St. Josef-Hospital, Ruhr University, 44791 Bochum, Germany.
  • Ettrich TJ; Department of Gastroenterology, Hepatology and Gastrointestinal Oncology, Klinikum Bogenhausen, 81925 Munich, Germany.
  • Zhang D; Department of Internal Medicine II, Leopoldina Krankenhaus Schweinfurt, 97422 Schweinfurt, Germany.
  • Held S; Department of Medical Oncology, University Hospital of Wuerzburg, 97080 Wuerzburg, Germany.
  • Abdul-Ahad A; Department of Internal Medicine I, University of Ulm, 89081 Ulm, Germany.
  • von Bergwelt-Baildon M; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig Maximilian University of Munich, Marchioninistr. 15, 81377 Munich, Germany.
  • Heinemann V; ClinAssess GmbH, Department of Biometry, 51379 Leverkusen, Germany.
  • Haas M; BOTh Analytics GmbH, 80687 Munich, Germany.
Curr Oncol ; 30(6): 5828-5834, 2023 06 17.
Article en En | MEDLINE | ID: mdl-37366919
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Exantema Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Exantema Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania